1.Powers JP, Piper DE, Li Y, Mayorga V, Anzola J, Chen JM, Jaen JC, Lee G, Liu J, Peterson MG, Tonn GR, Ye Q, Walker NP, Wang Z.. (2006) SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase., 49 (3):[PMID:16451069][10.1021/jm050859x]
2.Sortino M, Delgado P, Juárez S, Quiroga J, Abonía R, Insuasty B, Nogueras M, Rodero L, Garibotto FM, Enriz RD, Zacchino SA.. (2007) Synthesis and antifungal activity of (Z)-5-arylidenerhodanines., 15 (1):[PMID:17049255][10.1016/j.bmc.2006.09.038]
3.Mustata G, Follis AV, Hammoudeh DI, Metallo SJ, Wang H, Prochownik EV, Lazo JS, Bahar I.. (2009) Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model., 52 (5):[PMID:19215087][10.1021/jm801278g]
4.Russell AJ, Westwood IM, Crawford MH, Robinson J, Kawamura A, Redfield C, Laurieri N, Lowe ED, Davies SG, Sim E.. (2009) Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2., 17 (2):[PMID:19059786][10.1016/j.bmc.2008.11.032]
5.Fan C, Clay MD, Deyholos MK, Vederas JC.. (2010) Exploration of inhibitors for diaminopimelate aminotransferase., 18 (6):[PMID:20185317][10.1016/j.bmc.2010.02.001]
6.Jadav SS, Sinha BN, Hilgenfeld R, Pastorino B, de Lamballerie X, Jayaprakash V.. (2015) Thiazolidone derivatives as inhibitors of chikungunya virus., 89 [PMID:25462237][10.1016/j.ejmech.2014.10.042]
